Prudential Financial
IOVA icon

Prudential Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Prudential Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Buy
64,310
+12,365
+24% +$47K ﹤0.01% 2137
2026
Q1 		$182K Buy
51,945
+34,280
+194% +$110K ﹤0.01% 2157
2025
Q4 		$48.2K Sell
17,665
-17,165
-49% -$39.7K ﹤0.01% 2149
2025
Q3 		$75.6K Hold
34,830
– – ﹤0.01% 2300
2025
Q2 		$177K Buy
34,830
+14,440
+71% +$35.9K ﹤0.01% 2231
2025
Q1 		$84.2K Sell
20,390
-11,310
-36% -$58.3K ﹤0.01% 2149
2024
Q4 		$235K Buy
31,700
+14,452
+84% +$134K ﹤0.01% 2052
2024
Q3 		$162K Sell
17,248
-54,162
-76% -$513K ﹤0.01% 2537
2024
Q2 		$573K Sell
71,410
-4,153
-5% -$44.5K ﹤0.01% 2110
2024
Q1 		$1.12M Buy
75,563
+60,668
+407% +$706K ﹤0.01% 1761
2023
Q4 		$121K Buy
14,895
+704
+5% +$3.68K ﹤0.01% 2489
2023
Q3 		$64.6K Buy
14,191
+974
+7% +$6.36K ﹤0.01% 2480
2023
Q2 		$93K Buy
13,217
+2,906
+28% +$20.8K ﹤0.01% 2488
2023
Q1 		$63K Sell
10,311
-247
-2% -$1.7K ﹤0.01% 2481
2022
Q4 		$67.5K Buy
10,558
+214
+2% +$1.67K ﹤0.01% 2474
2022
Q3 		$99K Sell
10,344
-1,019
-9% -$11.8K ﹤0.01% 2514
2022
Q2 		$123K Buy
+11,363
New +$149K ﹤0.01% 2512
2021
Q1 		– Sell
-39,945
Closed -$1.85M – 2514
2020
Q4 		$1.85M Buy
+39,945
New +$1.59M ﹤0.01% 1450
2020
Q2 		– Sell
-7,714
Closed -$231K – 2430
2020
Q1 		$231K Sell
7,714
-658
-8% -$17.4K ﹤0.01% 2146
2019
Q4 		$232K Buy
+8,372
New +$190K ﹤0.01% 2291
2019
Q3 		– Sell
-8,640
Closed -$212K – 2442
2019
Q2 		$212K Buy
+8,640
New +$130K ﹤0.01% 2322

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Prudential Financial's IOVA Position: Q2 2026 in Review

Prudential Financial increased its Iovance Biotherapeutics (IOVA) stake by 24% in Q2 2026, buying an estimated $47K and bringing the position to 64,310 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Prudential Financial first reported a position in IOVA in Q2 2019 and has held it in 21 quarters since. The position peaked at $1.85M in Q4 2020. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Prudential Financial held 64,310 shares of Iovance Biotherapeutics worth $268K as of Q2 2026.
  • Prudential Financial bought 12,365 Iovance Biotherapeutics shares in Q2 2026, an estimated $47K.
  • Iovance Biotherapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2137 holding.
  • Prudential Financial first reported a position in Iovance Biotherapeutics in Q2 2019 and has held it in 21 quarters since.
  • Prudential Financial's Iovance Biotherapeutics position peaked at $1.85M in Q4 2020.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.